Siderophore–Antibiotic Conjugate Design: New Drugs for Bad Bugs?
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Antibiotic resistance is a global health concern and a current threat to modern medicine and society. New strategies for antibiotic drug design and delivery offer a glimmer of hope in a currently limited pipeline of new antibiotics. One strategy involves conjugating iron-chelating microbial siderophores to an antibiotic or antimicrobial agent to enhance uptake and antibacterial potency. Cefiderocol (S-649266) is a promising cephalosporin–catechol conjugate currently in phase III clinical trials that utilizes iron-mediated active transport and demonstrates enhanced potency against multi-drug resistant (MDR) Gram-negative pathogens. Such molecules demonstrate that siderophore–antibiotic conjugates could be important future medicines to add to our antibiotic arsenal. This review is written in the context of the chemical design of siderophore–antibiotic conjugates focusing on the differing siderophore, linker, and antibiotic components that make up conjugates. We selected chemically distinct siderophore–antibiotic conjugates as exemplary conjugates, rather than multiple analogues, to highlight findings to date. The review should offer a general guide to the uninitiated in the molecular design of siderophore–antibiotic conjugates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782 · cited 1×
“Such mechanisms include the overexpression of the antibiotic target enzyme/protein, mutations in the antibiotic target protein/enzyme, overexpression of antibiotic-modifying enzymes such as β-lactamases, and the utilization of multiple efflux pumps to actively export the antibiotic out of the bacterial cell, reducing…”
BackgroundChemistry and biology of siderophores
Hider, R. C., & Kong, X. (2010) · Natural Product Reports · doi:10.1039/b906679a · Cited by 1,722 · cited 5×
“The solubility of iron at physiological pH in the aerobic environment is very low, as the presence of oxygen oxidizes Fe(II) into insoluble Fe(III) ferric oxyhydroxides [6].”
BackgroundInfluentialIto, A., Nishikawa, T., Matsumoto, S., Yoshizawa, H., Sato, T., Nakamura, R., Tsuji, M., & Yamano, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-16 · Cited by 352 · cited 3×
“Many functional groups have been incorporated into synthetic conjugates to form the basis of the linker, including but not limited to: amino acids [22], succinic acid [39], alkyl chains [14], polyethylene glycol (PEG) chains [10], triazoles [40], acetal groups [41], disulfide bonds [42], thiol-maleimides [43], citric…”
BackgroundRecent developments in understanding the iron acquisition strategies of gram positive pathogens
Sheldon, J. R., & Heinrichs, D. E. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv009 · Cited by 272 · cited 1×
“Generally, catecholate moieties can provide a good starting point for siderophore–antibiotic conjugates, as the catecholate moiety is recognized by a number of bacterial species for uptake, particularly in Gram-negative bacteria [27], but also as a xenosiderophore by a number of Gram-positive bacteria [28], and even b…”
BackgroundActive transport of iron and siderophore antibiotics
Braun, V (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00298-9 · Cited by 188
Schalk, I. J., & Guillon, L. (2013) · Amino Acids · doi:10.1007/s00726-013-1468-2 · Cited by 167 · cited 2×
“In Gram-negative bacteria, ferrisiderophores cross the outer membrane periplasm, and the inner membrane to reach the cytoplasm, where Fe(III) in the ferrisiderophore is reduced to Fe(II) and released; alternatively, free iron can be released from the ferrisiderophore in the periplasm for internalization to the cytopla…”
BackgroundAdaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa
Tomaras, A. P., Crandon, J. L., McPherson, C. J., Banevicius, M. A., Finegan, S. M., Irvine, R. L., Brown, M. F., O'Donnell, J. P., & Nicolau, D. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00629-13 · Cited by 110
Cited by
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Metals to combat antimicrobial resistance
Frei, A., Verderosa, A. D., Elliott, A. G., Zuegg, J., & Blaskovich, M. A. T. (2023) · Nature Reviews Chemistry · doi:10.1038/s41570-023-00463-4 · Cited by 638
Critical analysis of antibacterial agents in clinical development
Theuretzbacher, U., Bush, K., Harbarth, S., Paul, M., Rex, J. H., Tacconelli, E., & Thwaites, G. E. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0340-0 · Cited by 373
Morris, S., & Cerceo, E. (2020) · Antibiotics · doi:10.3390/antibiotics9040196 · Cited by 287
Siderophores: A Case Study in Translational Chemical Biology
LeBlanc, A. R., & Wuest, W. M. (2024) · Biochemistry · doi:10.1021/acs.biochem.4c00276 · Cited by 20
Metadata
- Authors
- Negash, K. H., Norris, J. K. S., & Hodgkinson, J. T.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2019-09-11
- Volume
- 24
- Issue
- 18
- Pages
- 3314
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2973158135
- Cited by
- 152
- References
- 7
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Siderophore–Antibiotic Conjugate Design: New Drugs for Bad Bugs? https://app.cochat.ai/papers/10.3390/molecules24183314
- The paper
- Negash, K. H., Norris, J. K. S., & Hodgkinson, J. T. (2019). Siderophore–Antibiotic Conjugate Design: New Drugs for Bad Bugs? Molecules. https://doi.org/10.3390/molecules24183314
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.